Publication Information

{'id': 'https://openalex.org/W1531780611', 'doi': None, 'title': 'Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.', 'display_name': 'Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.', 'publication_year': 1996, 'publication_date': '1996-06-01', 'ids': {'openalex': 'https://openalex.org/W1531780611', 'mag': '1531780611', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/8653700'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8653700', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5113764739', 'display_name': 'H Kusumoto', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1313298211', 'display_name': "St. Jude Children's Research Hospital", 'ror': 'https://ror.org/02r3e0967', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1313298211', 'https://openalex.org/I2802152183']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'H Kusumoto', 'raw_affiliation_strings': ["Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA."], 'affiliations': [{'raw_affiliation_string': "Department of Molecular Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.", 'institution_ids': ['https://openalex.org/I1313298211']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069496095', 'display_name': 'Queen E. Rodgers', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Q E Rodgers', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058562579', 'display_name': 'Fritz Boege', 'orcid': 'https://orcid.org/0000-0002-0780-1033'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'F Boege', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012776569', 'display_name': 'Susana C. Raimondi', 'orcid': 'https://orcid.org/0000-0001-8155-3018'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'S C Raimondi', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5059498891', 'display_name': 'William T. Beck', 'orcid': 'https://orcid.org/0000-0001-9388-8077'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'W T Beck', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.901, 'has_fulltext': False, 'cited_by_count': 21, 'citation_normalized_percentile': {'value': 0.633943, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 85, 'max': 86}, 'biblio': {'volume': '56', 'issue': '11', 'first_page': '2573', 'last_page': '83'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9997, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13160', 'display_name': 'Synthesis and Biological Evaluation', 'score': 0.9843, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9638, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/amsacrine', 'display_name': 'Amsacrine', 'score': 0.89579576}, {'id': 'https://openalex.org/keywords/teniposide', 'display_name': 'Teniposide', 'score': 0.84773487}, {'id': 'https://openalex.org/keywords/camptothecin', 'display_name': 'Camptothecin', 'score': 0.567898}, {'id': 'https://openalex.org/keywords/topoisomerase-inhibitor', 'display_name': 'Topoisomerase inhibitor', 'score': 0.5084073}], 'concepts': [{'id': 'https://openalex.org/C2780500152', 'wikidata': 'https://www.wikidata.org/wiki/Q2784004', 'display_name': 'Amsacrine', 'level': 4, 'score': 0.89579576}, {'id': 'https://openalex.org/C2778119113', 'wikidata': 'https://www.wikidata.org/wiki/Q418817', 'display_name': 'Etoposide', 'level': 3, 'score': 0.8769226}, {'id': 'https://openalex.org/C2778707968', 'wikidata': 'https://www.wikidata.org/wiki/Q417555', 'display_name': 'Teniposide', 'level': 4, 'score': 0.84773487}, {'id': 'https://openalex.org/C147897179', 'wikidata': 'https://www.wikidata.org/wiki/Q407828', 'display_name': 'Topoisomerase', 'level': 3, 'score': 0.8057103}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.5908573}, {'id': 'https://openalex.org/C2778143360', 'wikidata': 'https://www.wikidata.org/wiki/Q421193', 'display_name': 'Podophyllotoxin', 'level': 2, 'score': 0.5790199}, {'id': 'https://openalex.org/C2779682216', 'wikidata': 'https://www.wikidata.org/wiki/Q419964', 'display_name': 'Camptothecin', 'level': 2, 'score': 0.567898}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.5384746}, {'id': 'https://openalex.org/C2778616834', 'wikidata': 'https://www.wikidata.org/wiki/Q281044', 'display_name': 'Topoisomerase inhibitor', 'level': 4, 'score': 0.5084073}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.5035388}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.3622324}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3307401}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.27892536}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.2202453}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.14102614}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.10553315}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.09777692}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.07920462}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': 'Q000201', 'qualifier_name': 'enzymology', 'is_major_topic': True}, {'descriptor_ui': 'D013858', 'descriptor_name': 'Thiobarbiturates', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D059005', 'descriptor_name': 'Topoisomerase II Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000782', 'descriptor_name': 'Aneuploidy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002478', 'descriptor_name': 'Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004268', 'descriptor_name': 'DNA-Binding Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004268', 'descriptor_name': 'DNA-Binding Proteins', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D004351', 'descriptor_name': 'Drug Resistance', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007621', 'descriptor_name': 'Karyotyping', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007938', 'descriptor_name': 'Leukemia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013858', 'descriptor_name': 'Thiobarbiturates', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D059004', 'descriptor_name': 'Topoisomerase I Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/8653700', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2468416386', 'https://openalex.org/W2396796971', 'https://openalex.org/W2344056970', 'https://openalex.org/W2099238800', 'https://openalex.org/W2069159742', 'https://openalex.org/W2006380088', 'https://openalex.org/W2001356417', 'https://openalex.org/W1946967684', 'https://openalex.org/W1598282819', 'https://openalex.org/W1531780611'], 'abstract_inverted_index': {'Merbarone': [0, 281], 'is': [1, 32, 362], 'a': [2, 120, 171, 202, 222, 260, 354, 381, 459], 'catalytic': [3, 49, 156, 371, 460], 'inhibitor': [4, 461], 'of': [5, 21, 39, 44, 100, 102, 124, 296, 322, 336, 383, 416, 426, 430, 440, 462, 473], 'DNA': [6], 'topoisomerase': [7], '(topo)': [8], 'II': [9, 15, 27, 145, 404, 477], 'that': [10, 107, 240, 348, 361, 365, 390, 424, 444], 'does': [11], 'not': [12, 52, 153, 189, 311], 'stabilize': [13], 'DNA-topo': [14], 'cleavable': [16], 'complexes.': [17], 'Although': [18], 'the': [19, 42, 94, 103, 125, 294, 305, 323, 346, 357, 413, 445, 449], 'cytotoxicity': [20, 45, 427], 'and': [22, 46, 110, 129, 150, 184, 188, 211, 213, 216, 227, 229, 232, 244, 264, 290, 333, 406, 419, 428, 454, 478], 'resistance': [23, 47, 207, 241, 358, 457], 'to': [24, 34, 48, 87, 90, 93, 142, 154, 169, 178, 242, 246, 255, 341, 359, 366, 370, 376, 438, 451, 458, 475], 'complex-stabilizing': [25, 143, 367], 'topo': [26, 144, 173, 180, 234, 328, 331, 337, 350, 385, 403, 463, 476, 479], 'inhibitors,': [28, 146, 157], 'such': [29], 'as': [30, 380], 'etoposide,': [31, 147], 'thought': [33], 'be': [35, 249, 258, 374, 397, 436, 452], 'mediated': [36], 'through': [37, 72, 250, 259], 'stabilization': [38], 'these': [40, 82, 164], 'complexes,': [41], 'mechanisms': [43, 425], 'inhibitors': [50, 182, 372, 405], 'are': [51, 85, 140, 167, 448], 'well': [53], 'known.': [54], 'To': [55], 'investigate': [56], 'this': [57], 'issue,': [58], 'we': [59, 422], 'established': [60], '12': [61, 197], 'merbarone-resistant': [62, 126], 'cell': [63, 83, 104, 112, 138, 165, 193, 198, 469], 'lines': [64, 84, 105, 113, 127, 139, 166, 470], 'from': [65, 364, 399, 411], 'human': [66], 'leukemia': [67], 'CEM': [68, 95, 109, 275, 342], 'cells,': [69, 276, 292], 'designated': [70], 'CEM/M70-B1': [71], '-B12.': [73], 'Assessed': [74], 'by': [75, 286, 316, 394, 402, 408], 'either': [76], 'growth': [77], 'inhibition': [78, 297], 'or': [79, 159, 318], 'clonogenic': [80], 'assay,': [81], '3.5-': [86], '6.6-fold': [88], 'resistant': [89], 'merbarone,': [91], 'compared': [92, 340], 'parent': [96], 'cells.': [97, 307, 343], 'Karyotype': [98], 'analysis': [99, 321], 'three': [101], 'revealed': [106], 'while': [108], 'drug-resistant': [111], 'had': [114, 132], 'chromosome': [115], 'abnormalities': [116], 'in': [117, 191, 270, 274, 288, 300, 304, 356, 432], 'common,': [118], 'indicating': [119], 'common': [121], 'origin,': [122], 'two': [123], '(B1': [128], 'B8)': [130], 'each': [131], 'unique': [133], 'structural': [134], 'markers.': [135], 'These': [136, 237], 'novel': [137, 468], 'cross-resistant': [141, 168], 'teniposide,': [148], 'amsacrine,': [149], 'doxorubicin,': [151], 'but': [152, 176, 277, 293], 'other': [155, 179, 233], 'aclarubicin': [158], 'SN-22995.': [160], 'Of': [161], 'considerable': [162], 'interest,': [163], 'SN-38,': [170], 'putative': [172], 'I': [174, 181, 235, 338, 480], 'inhibitor,': [175], 'cross-resistance': [177, 245, 254, 429], '(camptothecin': [183], 'topotecan)': [185], 'was': [186, 201, 221, 298], 'lower': [187, 299], 'seen': [190], 'every': [192], 'line.': [194], 'In': [195], 'all': [196], 'lines,': [199], 'there': [200, 220], 'high': [203, 414], 'correlation': [204, 224, 415], 'among': [205], 'drug': [206, 417], 'ratios': [208], 'between': [209, 214, 225, 230], 'etoposide': [210, 228, 247, 287], 'teniposide': [212], 'merbarone': [215, 226, 243, 309, 360], 'SN-38.': [217], 'By': [218], 'contrast,': [219], 'low': [223], 'SN-38': [231, 256, 265, 317, 395, 431], 'inhibitors.': [236, 481], 'results': [238], 'suggest': [239], 'might': [248, 257, 396, 435], 'different': [251, 363, 398], 'mechanisms,': [252], 'whereas': [253], 'merbarone-related': [261], 'mechanism.': [262], 'Etoposide': [263], 'stabilized': [266, 279, 315, 393, 401], 'fewer': [267], 'DNA-topoisomerase': [268], 'complexes': [269, 392], 'CEM/M70-B': [271, 301, 324, 433, 446], 'cells': [272, 302, 325, 434, 447], 'than': [273, 303], 'camptothecin': [278], 'more.': [280], 'inhibited': [282], 'complex': [283, 313, 378], 'formation': [284, 314, 379], 'induced': [285], 'drug-sensitive': [289], '-resistant': [291], 'degree': [295], 'parental': [306], 'Moreover,': [308], 'did': [310], 'affect': [312], 'camptothecin.': [319], 'Immunoblot': [320], 'showed': [326], 'decreased': [327, 349, 384], 'IIalpha,': [329], 'increased': [330], 'IIbeta,': [332], 'no': [334], 'change': [335], 'protein,': [339], 'We': [344, 387, 442], 'propose': [345], 'hypothesis': [347], 'IIalpha': [351], 'may': [352, 373], 'play': [353], 'role': [355], 'drugs.': [368], 'Cross-resistance': [369], 'due': [375], 'reduced': [377], 'consequence': [382], 'IIalpha.': [386], 'also': [388], 'found': [389], 'DNA-protein': [391], 'those': [400, 439], 'blocked': [407], 'merbarone.': [409, 441], 'Judging': [410], 'both': [412], 'sensitivities': [418], 'complex-formation': [420], 'assays,': [421], 'postulate': [423], 'similar': [437], 'believe': [443], 'first': [450], 'selected': [453], 'characterized': [455], 'for': [456], 'II.': [464], 'This': [465], 'study': [466], 'provides': [467], 'with': [471], 'characteristics': [472], 'resistances': [474]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1531780611', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-14T11:29:33.676674', 'created_date': '2016-06-24'}